n-vinyl-2-pyrrolidinone has been researched along with Diabetic Feet in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carretero, JH; Duarte, HA; Fernández Montequín, JI; Fors López, MM; Mesa, MG; Vilas, MM | 1 |
| Alvarez Duarte, H; Carretero, JH; Fors López, MM; García Mesa, M; Vilas, MM | 1 |
| Carretero, JH; Duarte, HÁ; López, MM; Mesa, MG; Vilas, MM | 1 |
3 trial(s) available for n-vinyl-2-pyrrolidinone and Diabetic Feet
| Article | Year |
|---|---|
Clinical evaluation of De Marco formula as an adjunctive therapy for infected ischemic diabetic foot: a prospective randomized controlled trial.
Topics: Aged; Amputation, Surgical; Anesthetics, Local; Diabetic Foot; Drug Combinations; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Ischemia; Male; Middle Aged; Povidone; Procaine; Prospective Studies; Treatment Outcome; Wound Healing; Wound Infection | 2009 |
Tolerability and safety of conventional therapy combination with DeMarco formula for infected ischemic diabetic foot.
Topics: Amputation, Surgical; Anesthetics, Local; Bacterial Infections; Combined Modality Therapy; Diabetic Foot; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Povidone; Procaine; Treatment Outcome | 2010 |
De Marco Formula effectiveness as an adjunctive therapy to prevent infected ischemic diabetic foot amputation and reduce plasma fibrinogen.
Topics: Adult; Aged; Amputation, Surgical; Anesthetics, Local; Bacterial Infections; Combined Modality Therapy; Diabetic Foot; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Povidone; Procaine; Prospective Studies; Toes; Wound Healing | 2011 |